Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Denali Capital Acquisition Corp. - Class A Ordinary Shares (NQ: DECA )

12.00 +0.58 (+5.08%)
Streaming Delayed Price Updated: 10:30 AM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Denali Capital Acquisition Corp. - Class A Ordinary Shares

Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate
Alliance Global Partners has initiated coverage on Scilex Holding Company. The company explores strategic options for its subsidiary, Scilex Pharma, including potential spinoffs and dividend... 
Via Benzinga
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
Semnur Pharmaceuticals, a subsidiary of Scilex, plans a business combination with Denali Capital Acquisition Corp. Semnur's lead product, SP-102 (SEMDEXA), a novel non-opioid pain therapy for sciatica,... 
Via Benzinga
Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning! 
Via InvestorPlace
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.